Jade Biosciences, Inc.

Biotechnology • Healthcare • Waltham, MA, United States • JBIO (NCM)

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. It also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.

781 312 3013 Building 23, Waltham, MA 02453, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week - Yahoo Finance

Yahoo Finance • Jan 6

The recent drop in prices must have disappointed Jade Biosciences, Inc. (NASDAQ:JBIO) institutional investors who own 53% of the shares - simplywall.st

simplywall.st • Jan 6

H.C. Wainwright initiates coverage on Jade Biosciences stock with Buy rating - Investing.com

Investing.com • Jan 7

Does Jade Biosciences, Inc. (JBIO) have the potential to rally 65% as Wall Street analysts expect? - MSN

MSN • Jan 6

HC Wainwright & Co. Initiates Coverage of Jade Biosciences (JBIO) with Buy Recommendation - Nasdaq

Nasdaq • Jan 7

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Jade Biosciences, Inc. had layoffs?

No layoff events have been recorded for Jade Biosciences, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Jade Biosciences, Inc. have?

Jade Biosciences, Inc. has approximately 30 employees.

What industry is Jade Biosciences, Inc. in?

Jade Biosciences, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Jade Biosciences, Inc. a publicly traded company?

Yes, Jade Biosciences, Inc. is publicly traded under the ticker symbol JBIO on the NCM. The company has a market capitalization of approximately $0.81 billion.

Where is Jade Biosciences, Inc. headquartered?

Jade Biosciences, Inc. is headquartered in Waltham, MA, United States at Building 23, Waltham, MA 02453, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.